NeutriSci International (FRA:1N9) Market Cap: €0.59 Mil (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is NeutriSci International Market Cap?

NeutriSci International FRA:1N9 Market Cap is €0.59 Mil as of Jul. 18, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). NeutriSci International's share price for the quarter that ended in Sep. 2023 was €0.0005. NeutriSci International's Shares Outstanding (EOP) for the quarter that ended in Sep. 2023 was 178.42 Mil. Therefore, NeutriSci International's market cap for the quarter that ended in Sep. 2023 was €0.09 Mil.

NeutriSci International's quarterly market cap declined from Mar. 2023 (€0.96 Mil) to Jun. 2023 (€0.09 Mil) but then stayed the same from Jun. 2023 (€0.09 Mil) to Sep. 2023 (€0.09 Mil).

NeutriSci International's annual market cap declined from Dec. 2020 (€10.42 Mil) to Dec. 2021 (€5.81 Mil) and declined from Dec. 2021 (€5.81 Mil) to Dec. 2022 (€1.13 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. NeutriSci International's Enterprise Value for Today is €0.73 Mil.

NeutriSci International  (FRA:1N9) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

NeutriSci International Market Cap Related Terms

NeutriSci International Market Cap Historical Data

* Premium members only.

The historical data trend for NeutriSci International's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeutriSci International Market Cap Chart

NeutriSci International Annual Data
Trend Mar13 Mar14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.93 1.27 10.42 5.81 1.13

NeutriSci International Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.22 1.13 0.96 0.09 0.09

FRA:1N9 vs ZTS, NBIX: Market Cap Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, NeutriSci International's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NeutriSci International Market Cap vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NeutriSci International's Market Cap distribution charts can be found below:

* The bar in red indicates where NeutriSci International's Market Cap falls into.


NeutriSci International Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

NeutriSci International's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )=Share Price (A: Dec. 2022 )*Shares Outstanding (EOP) (A: Dec. 2022 )
=€0.0064*175.963
=€1.13

NeutriSci International's Market Cap for the quarter that ended in Sep. 2023 is calculated as

Market Cap (Q: Sep. 2023 )=Share Price (Q: Sep. 2023 )*Shares Outstanding (EOP) (Q: Sep. 2023 )
=€0.0005*178.424
=€0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of €0.59 Mil mean?
NeutriSci International (FRA:1N9) has a Market Cap of €0.59 Mil as of Jul. 18, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on NeutriSci International and its competitors.
Is NeutriSci International's Market Cap too high?
NeutriSci International's current Market Cap is €0.59 Mil.
How does NeutriSci International's Market Cap compare to ZTS and NBIX?
NeutriSci International's Market Cap of €0.59 Mil can be compared against companies in the Drug Manufacturers industry. The industry median Market Cap is 225.62. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 225.62, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on NeutriSci International and its competitors. For the Drug Manufacturers industry, the median Market Cap is 225.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NeutriSci International's current Market Cap is €0.59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeutriSci International stock overvalued right now?
NeutriSci International (FRA:1N9) has a current Market Cap of €0.59 Mil. The current Market Cap is €0.59 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For NeutriSci International (FRA:1N9), the current Market Cap is €0.59 Mil as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NeutriSci International Business Description

Address 609 Granville Street, Suite 1600, Vancouver, BC, CAN, V7Y 1C3
NeutriSci International Inc specializes in the production and formulation of nutraceutical products within the B2B industry. By incorporating natural ingredients, it implements industry disrupting patent pending Cryolization Technology to provide B2B partners with the ability to create unparalleled products. Using patent pending proprietary ingredients, technologies, and IP, it can help bring to market effective, solution-oriented products that meet the needs of consumers. The company continues to develop emerging sales channels in the USA, European, Asian & South American markets.